FR2809399B1 - Nouveaux derives d'ascididemine et leurs applications therapeutiques - Google Patents

Nouveaux derives d'ascididemine et leurs applications therapeutiques

Info

Publication number
FR2809399B1
FR2809399B1 FR0006652A FR0006652A FR2809399B1 FR 2809399 B1 FR2809399 B1 FR 2809399B1 FR 0006652 A FR0006652 A FR 0006652A FR 0006652 A FR0006652 A FR 0006652A FR 2809399 B1 FR2809399 B1 FR 2809399B1
Authority
FR
France
Prior art keywords
ascididemine
derivatives
new
therapeutic applications
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0006652A
Other languages
English (en)
Other versions
FR2809399A1 (fr
Inventor
Evelyne Delfourne
Francis Darro
Jean Bastide
Robert Kiss
Armand Frydman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cephalon France SAS
Original Assignee
Laboratoire L Lafon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0006652A priority Critical patent/FR2809399B1/fr
Application filed by Laboratoire L Lafon SA filed Critical Laboratoire L Lafon SA
Priority to CA002393965A priority patent/CA2393965A1/fr
Priority to CZ2002528A priority patent/CZ2002528A3/cs
Priority to PL00353453A priority patent/PL353453A1/xx
Priority to AU70124/00A priority patent/AU779932B2/en
Priority to DK00958678T priority patent/DK1202992T3/da
Priority to AT00958678T priority patent/ATE276256T1/de
Priority to PT00958678T priority patent/PT1202992E/pt
Priority to PCT/FR2000/002312 priority patent/WO2001012631A2/fr
Priority to DE60013849T priority patent/DE60013849T2/de
Priority to IL14790000A priority patent/IL147900A0/xx
Priority to BR0013249-7A priority patent/BR0013249A/pt
Priority to SK166-2002A priority patent/SK1662002A3/sk
Priority to JP2001517529A priority patent/JP2003507381A/ja
Priority to MXPA02001512A priority patent/MXPA02001512A/es
Priority to CNB008126569A priority patent/CN1195754C/zh
Priority to ES00958678T priority patent/ES2228602T3/es
Priority to HU0202767A priority patent/HUP0202767A3/hu
Priority to EP00958678A priority patent/EP1202992B1/fr
Priority to NZ516896A priority patent/NZ516896A/en
Publication of FR2809399A1 publication Critical patent/FR2809399A1/fr
Priority to NO20020668A priority patent/NO20020668L/no
Application granted granted Critical
Publication of FR2809399B1 publication Critical patent/FR2809399B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0006652A 1999-08-13 2000-05-24 Nouveaux derives d'ascididemine et leurs applications therapeutiques Expired - Fee Related FR2809399B1 (fr)

Priority Applications (21)

Application Number Priority Date Filing Date Title
FR0006652A FR2809399B1 (fr) 2000-05-24 2000-05-24 Nouveaux derives d'ascididemine et leurs applications therapeutiques
MXPA02001512A MXPA02001512A (es) 1999-08-13 2000-08-11 Derivados de ascididemina y sus aplicaciones terapeuticas.
JP2001517529A JP2003507381A (ja) 1999-08-13 2000-08-11 フェナントロリン−７−オン誘導体及びその治療への使用
AU70124/00A AU779932B2 (en) 1999-08-13 2000-08-11 Ascididemin derivatives and their therapeutic applications
CZ2002528A CZ2002528A3 (cs) 1999-08-13 2000-08-11 Derivát ascidideminu, způsob jeho přípravy a farmaceutický prostředek, který ho obsahuje
AT00958678T ATE276256T1 (de) 1999-08-13 2000-08-11 Ascidideminderivate und ihre therapeutische verwendung
PT00958678T PT1202992E (pt) 1999-08-13 2000-08-11 Derivados de ascididemina e suas aplicacoes terapeuticas
CNB008126569A CN1195754C (zh) 1999-08-13 2000-08-11 菲咯啉－7－酮衍生物以及它们的治疗用途
DE60013849T DE60013849T2 (de) 1999-08-13 2000-08-11 Ascidideminderivate und ihre therapeutische verwendung
IL14790000A IL147900A0 (en) 1999-08-13 2000-08-11 Ascididemin derivatives and their therapeutic applications
CA002393965A CA2393965A1 (fr) 1999-08-13 2000-08-11 Derives d'ascididemine et leurs applications therapeutiques
SK166-2002A SK1662002A3 (en) 1999-08-13 2000-08-11 Ascididemin derivative, method for the preparation thereof and pharmaceutical composition containing the same
PL00353453A PL353453A1 (en) 1999-08-13 2000-08-11 Ascididemin derivatives and their therapeutic applications
DK00958678T DK1202992T3 (da) 1999-08-13 2000-08-11 Ascididemin-derivater og terapeutiske anvendelser deraf
PCT/FR2000/002312 WO2001012631A2 (fr) 1999-08-13 2000-08-11 Derives d'ascididemine et leurs applications therapeutiques
ES00958678T ES2228602T3 (es) 1999-08-13 2000-08-11 Derivados de asdididemina y sus aplicaciones terapeuticas.
HU0202767A HUP0202767A3 (en) 1999-08-13 2000-08-11 Ascididemin derivatives, process for their preparation and pharmaceutical compositions containing them
EP00958678A EP1202992B1 (fr) 1999-08-13 2000-08-11 Derives d'ascididemine et leurs applications therapeutiques
NZ516896A NZ516896A (en) 1999-08-13 2000-08-11 Ascididemin derivatives and their therapeutic applications
BR0013249-7A BR0013249A (pt) 1999-08-13 2000-08-11 Derivados de ascididemina e suas aplicações terapêuticas
NO20020668A NO20020668L (no) 1999-08-13 2002-02-11 Ascidideminderivater og deres terapeutiske anvendelser

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0006652A FR2809399B1 (fr) 2000-05-24 2000-05-24 Nouveaux derives d'ascididemine et leurs applications therapeutiques

Publications (2)

Publication Number Publication Date
FR2809399A1 FR2809399A1 (fr) 2001-11-30
FR2809399B1 true FR2809399B1 (fr) 2004-04-16

Family

ID=8850577

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0006652A Expired - Fee Related FR2809399B1 (fr) 1999-08-13 2000-05-24 Nouveaux derives d'ascididemine et leurs applications therapeutiques

Country Status (1)

Country Link
FR (1) FR2809399B1 (fr)

Also Published As

Publication number Publication date
FR2809399A1 (fr) 2001-11-30

Similar Documents

Publication Publication Date Title
CY2013011I1 (el) Μεθοδος χορηγησης διφωσφονικων
DK1354888T3 (da) Glukopyranosyloxypyrazolderivater og anvendelse deraf i medikamenter
ATE411332T1 (de) 3'-prodrugs von 2'-deoxy-beta-l-nukleosiden
NO20031407L (no) Glukopyranosyloksybenzylbenzen-derivater og medisinske sammensetninger inneholdende det samme
FR2807810B1 (fr) Structure d'amortissement et applications
FR2840614B1 (fr) Polyaminoacides fonctionnalises par de l'alpha-tocopherol et leurs applications notamment therapeutiques
FR2818646B1 (fr) Nouveaux derives c-glycoside et utilisation
FR2804113B1 (fr) Derives animes de dihydro-1,3,5-triazine et leurs applications en therapeutique
LV12624A (lv) Thienylazolylalcoxyethanamines their preparation and their application as medicaments
ATE275938T1 (de) Stabiles und wirksames weiches feststoffprodukt
DE60032946D1 (de) Katheter
ITMI20001827A0 (it) Medicamento antinfiammatorio
MA26941A1 (fr) Nouveaux derives d'aminocyclohexane
NO20042693L (no) Kateterpreparat og anvendelser derav
FR2792318B1 (fr) Derives d'indazole, leur preparation et leur application en therapeutique
FR2779429B1 (fr) Derives d'oxindole, leurs preparations et leurs applications en therapeutique
FR2842808B1 (fr) Nouveaux derives d'arylimidazoles, leur preparation et leurs applications therapeutiques
MA27240A1 (fr) Derives d'imidazoquinoleine
FR2779146B1 (fr) Nouveaux derives de vinca-alcaloides et procedes de preparation
PT1178981E (pt) 3-piridil-4-arilpirrois substituidos e metodos terapeuticos e profilacticos
FR2842527B1 (fr) Derives d'acyloxypyrolidine, leur preparation et leur application en therapeutique
FR2809399B1 (fr) Nouveaux derives d'ascididemine et leurs applications therapeutiques
MA25653A1 (fr) Derives d'amides heterocycliques.
FR2834991B1 (fr) Nouveaux anticorps anti-igf-ir et leurs applications
FR2814166B1 (fr) Derives 5-phenoxyindole et leurs applications therapeutiques

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20070131